ArticleEJNMMI research2020
Day-to-day variability of [
Article in EJNMMI research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 15 citations in OpenAlex.
- Predicting [EJNMMI physics · 2023Article
- Impact of [Cancers · 2023Article
- Predicting the effect of different folate doses on [EJNMMI research · 2023Article
- Intra-Individual Comparison of Physiologic [Cancers · 2023Article
- Article
- Tumor Sink Effect inJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022Article
- Intraindividual comparison of [EJNMMI research · 2021Article
- Is SUV Corrected for Lean Body Mass Superior to SUV of Body Weight inMolecular imaging and radionuclide therapy · 2021Article
- Evaluation of Quantitative Ga-68 PSMA PET/CT Repeatability of Recurrent Prostate Cancer Lesions Using Both OSEM and Bayesian Penalized Likelihood Reconstruction Algorithms.Diagnostics (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
Abstract
purposeProstate-specific membrane antigen (PSMA) agents, such as [
methodsTwenty-four primary PCa patients were prospectively included, who already were scheduled for [
resultsWithin-subject coefficient of variation of [
conclusionResults of test-retest [
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.